Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genox is a U.S.-based life science tools and biomarker company focused on oxidative stress research products and related analytical services. The company markets ELISA kits, antibodies, antioxidant assays, and trace element assay products used in aging, disease prevention, toxicity, and nutrition research. Genox positions itself around the development and commercialization of oxidative stress biomarkers, particularly for measuring DNA, lipid, and protein oxidation. It operates as a subsidiary of Nikken SEIL of Japan and serves as the distributor for these products in North and South America. The business appears to be commercial-stage rather than a therapeutic drug developer, with revenue generated from research-use products and services rather than a clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genox.